Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.8K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diffuse Large B-Cell Lymphoma: From Molecular Stratification to Precision Immunotherapy.

Cells·2026
Same author

Targeted metabolomic profiling of gastric cancer biopsies.

The Indian journal of medical research·2026
Same author

Combination treatment with mitoxantrone and doxorubicin induces multidrug resistance in Ewing Sarcoma CDX reporter xenografts.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Development of single chain antibodies for targeting Ewing sarcoma surface marker CD99.

Biochemical and biophysical research communications·2026
Same author

Exploring the Potential of MXenes for Biomedical and Environmental Applications-An Abridged Review.

Luminescence : the journal of biological and chemical luminescence·2025
Same author

Druggable upregulated proteins in EWS-FLI-driven Ewing sarcoma as emerging new therapeutic targets.

American journal of translational research·2025

Related Experiment Video

Updated: Oct 8, 2025

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.6K

Challenges in modeling EWS-FLI1-driven transgenic mouse model for Ewing sarcoma.

Balaji Ramachandran1, Thangarajan Rajkumar1, Gopal Gopisetty1

  • 1Department of Molecular Oncology, Cancer Institute (W.I.A) No. 38, Sardar Patel Road, Adyar, Chennai 600036, India.

American Journal of Translational Research
|December 27, 2021
PubMed
Summary

Developing targeted therapies for Ewing sarcoma (ES) is crucial, but EWS-FLI1-driven mouse models have faced challenges. This review explores limitations and alternatives for advancing EWS-FLI1 inhibitor development.

Keywords:
EWS-FLI1Ewing sarcomafusion proteinmouse modelsprogenitor cellstumor cell of origin

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.3K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.9K

Related Experiment Videos

Last Updated: Oct 8, 2025

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.6K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.3K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ewing sarcoma (ES) oncogenesis is driven by the EWS-FLI1 fusion protein, a key therapeutic target.
  • Despite extensive research on EWS-FLI1's role, effective targeted inhibitors remain elusive.
  • Current therapeutic strategies for ES are limited due to the lack of specific inhibitors targeting EWS-FLI1.

Purpose of the Study:

  • To review the current challenges and limitations in developing EWS-FLI1-driven preclinical models for Ewing sarcoma.
  • To identify reasons for the limited success of previous attempts in creating human-like ES mouse models.
  • To explore potential interim alternatives for accelerating the development of EWS-FLI1 targeted therapeutic inhibitors.

Main Methods:

  • Literature review of scientific publications on EWS-FLI1, Ewing sarcoma pathogenesis, and preclinical model development.
  • Analysis of reported limitations and challenges in establishing EWS-FLI1-driven in vivo systems.
  • Exploration of alternative strategies and their potential clinical relevance.

Main Results:

  • Significant information exists on EWS-FLI1 translocation, pathogenesis, and function.
  • Past attempts to create EWS-FLI1-driven human-like ES mouse models have yielded limited success.
  • The development of reliable preclinical models is hindered by various technical and biological challenges.

Conclusions:

  • Establishing robust EWS-FLI1-driven preclinical models is critical for advancing targeted therapies in ES.
  • Understanding the limitations of past model development is essential for future research.
  • Exploring and validating interim alternatives may expedite the discovery of novel EWS-FLI1 inhibitors.